Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Hyperglycemia × Alpelisib × Clear all

Status

Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 14 Neoplasm Metastasis 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Hyperglycemia 1 Hormone Receptor Positive Breast Carcinoma 1 HER2-positive Metastatic Breast Cancer 1 Genetic Diseases, Inborn 1 Endometrial Neoplasms 1 Carcinoma, Ductal, Breast 1 Advanced HER2+Breast Cancer 1 Advanced Breast Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06083038 2025-12-31

Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib

HealthPartners Institute

Active not recruiting

Breast Neoplasms, Hyperglycemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡